Hyman Niznik - Publications
Affiliations: | University of Toronto, Toronto, ON, Canada |
Year | Citation | Score | |||
---|---|---|---|---|---|
2005 | Verma V, Mann A, Costain W, Pontoriero G, Castellano JM, Skoblenick K, Gupta SK, Pristupa Z, Niznik HB, Johnson RL, Nair VD, Mishra RK. Modulation of agonist binding to human dopamine receptor subtypes by L-prolyl-L-leucyl-glycinamide and a peptidomimetic analog. The Journal of Pharmacology and Experimental Therapeutics. 315: 1228-36. PMID 16126839 DOI: 10.1124/Jpet.105.091256 | 0.547 | |||
2004 | Jiang C, Wan X, Jankovic J, Christian ST, Pristupa ZB, Niznik HB, Sundsmo JS, Le W. Dopaminergic properties and experimental anti-parkinsonian effects of IPX750 in rodent models of Parkinson disease. Clinical Neuropharmacology. 27: 63-73. PMID 15252266 DOI: 10.1097/00002826-200403000-00004 | 0.304 | |||
2004 | Le Crom S, Sugamori KS, Sidhu A, Niznik HB, Vernier P. Delineation of the conserved functional properties of D1A, D1B and D1C dopamine receptor subtypes in vertebrates. Biology of the Cell / Under the Auspices of the European Cell Biology Organization. 96: 383-94. PMID 15207908 DOI: 10.1016/J.Biolcel.2004.03.002 | 0.556 | |||
2002 | Lee FJ, Xue S, Pei L, Vukusic B, Chéry N, Wang Y, Wang YT, Niznik HB, Yu XM, Liu F. Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell. 111: 219-30. PMID 12408866 DOI: 10.1016/S0092-8674(02)00962-5 | 0.477 | |||
Show low-probability matches. |